Capillary electrophoresis for biopharma

01Overview and value chain#

Markers EC: US FDA 21 CFR Part 11 + USP <129>/<1053> for capillary electrophoresis method validation | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)

Capillary electrophoresis (CE) separates charged molecules by pulling them through a thin fused-silica capillary under high voltage, replacing slab-gel electrophoresis with an automated, higher-resolution, lower-sample-volume format across three distinct applications. Capillary gel electrophoresis with SDS (CE-SDS) separates proteins by size under denaturing conditions for a quantitative purity assay, the automated equivalent of a traditional SDS-PAGE gel but with far better precision and no gel-to-gel variability. Imaged capillary isoelectric focusing (icIEF) separates protein charge variants — the acidic and basic species that arise from deamidation, glycation and other post-translational modifications — directly visualizing the focused bands with a camera rather than mobilizing them past a fixed detector, cutting analysis time from hours to minutes. Microfluidic chip electrophoresis miniaturizes the same separation principle onto a disposable chip for rapid nucleic-acid fragment sizing, an important QC step for plasmid DNA and mRNA manufacturing. Coupled to mass spectrometry, CE-MS adds molecular identity to the separation, turning a purity or charge-variant profile into a combined identity-and-purity characterization.

The key directions of capillary electrophoresis for biopharma are:

1. CE-SDS purity assays (CE-SDS): capillary gel electrophoresis under denaturing conditions replaces traditional SDS-PAGE with automated, quantitative protein-purity determination and far lower gel-to-gel variability.
2. Imaged capillary isoelectric focusing (icIEF): direct camera imaging of focused charge-variant bands compresses charge-heterogeneity analysis from hours to minutes versus mobilized cIEF.
3. Microfluidic chip electrophoresis (Chip-Based CE): disposable-chip miniaturized electrophoresis for rapid nucleic-acid fragment sizing, an important QC step for plasmid DNA and mRNA manufacturing.
4. CE-mass spectrometry (CE-MS): capillary electrophoresis coupled directly to a mass spectrometer’s ionization source, combining a high-resolution separation with molecular identity confirmation.

Sectoral value chain#

[Sample: protein/nucleic acid] ──> [Capillary/chip loading] ──> [High-voltage separation] ──> [Detection: UV/fluorescence/imaging/MS]
                                                                  │
                                                          (peak/band assignment)
                                                                  │
                                                                  ▼
[Purity/charge-variant/identity report] <─── [Software: electropherogram integration, image analysis]

Value chain levels#

Cross-cutting technologies of the sector:

• Multi-capillary parallel systems: running 8, 12 or more capillaries simultaneously multiplies sample throughput for high-volume QC and characterization workflows.
• Automated method-transfer software: vendor tools translate a validated CE-SDS or icIEF method between instrument generations while preserving resolution and precision.
• AI-assisted peak/band deconvolution: newer software increasingly assists automated integration of closely spaced charge-variant peaks that would otherwise require manual review.

02US#

The US hosts the category’s largest instrument makers, spanning CE-MS proteomics through CE-SDS/icIEF release testing and microfluidic nucleic-acid QC.

CE-MS proteomics, charge-variant analysis, microfluidic nucleic-acid sizing#

• SCIEX: the CESI 8000 Plus couples capillary electrophoresis directly to electrospray-ionization mass spectrometry, and the BioPhase 8800 system adds a native fluorescence detection module for higher-sensitivity biopharma characterization.
• Agilent Technologies: the 7100 CE system offers a 50-position autosampler carousel with a real-time UV-Vis diode-array detector, supporting both general CE and CE-MS workflows.
• Revvity: the LabChip GX platform miniaturizes capillary electrophoresis onto a microfluidic chip for rapid nucleic-acid fragment sizing, an application vendors are actively optimizing for plasmid DNA and mRNA/gene-therapy QC.
• ProteinSimple (Bio-Techne): the Maurice system integrates icIEF and CE-SDS on one automated platform, with the Maurice C variant offering a dedicated cIEF-only configuration for identity and charge-heterogeneity testing.

03CN#

No China-headquartered capillary electrophoresis instrument maker cleared this screening round with confirmed, on-domain evidence; demand is driven by China’s expanding biopharma characterization and QC-release base, currently served largely through the global vendors' regional distribution and applications-support networks.

import-dependent instrumentation, domestic biopharma QC demand, distributor-served market#

• Global vendor distribution: SCIEX, Agilent, Revvity, ProteinSimple and Qiagen each maintain China sales and applications-support organizations serving domestic biopharma and genomics manufacturers.
• Domestic biopharma QC build-out: China’s growing biologics and mRNA/gene-therapy manufacturing base is the main demand driver for capillary electrophoresis, without a confirmed domestic instrument originator identified in this screen.
• Screening note: two candidate China-headquartered instrument makers were probed and neither returned confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed.

04EU#

Germany’s Qiagen anchors Europe’s contribution with a nucleic-acid-focused capillary electrophoresis platform distinct from the US vendors’ protein-characterization focus.

automated nucleic-acid fragment analysis, ready-to-run gel cartridges, DNA/RNA QC platforms#

• Qiagen (Germany): the QIAxcel Connect automated capillary electrophoresis system targets fast, high-sensitivity, high-resolution DNA fragment analysis and RNA QC using ready-to-run gel cartridges, positioned as an accessible alternative to slab-gel electrophoresis for smaller labs.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack layers capillary or chip-based separation physics, detection mode and peak/band-assignment software, with the choice of platform driven by whether the application needs protein purity, charge-variant, nucleic-acid sizing, or combined identity data.

1. Capillary gel electrophoresis with SDS (CE-SDS):
   • Proteins denatured with SDS migrate through a sieving polymer matrix inside the capillary, separating by size under an applied high voltage.
   • Automated multi-capillary systems replace manual slab-gel casting and staining, delivering quantitative purity results with far lower run-to-run variability.
2. Imaged capillary isoelectric focusing (icIEF):
   • Proteins focus at their isoelectric point along a pH gradient inside the capillary; a whole-capillary camera image captures the focused bands directly, without mobilizing them past a fixed detector.
   • Cuts charge-variant analysis time from the roughly hour-long mobilized cIEF method to minutes, while preserving resolution of closely spaced acidic and basic species.
3. Microfluidic chip electrophoresis:
   • A disposable chip miniaturizes the capillary-separation channel, reducing sample and reagent volume while enabling rapid, automated nucleic-acid fragment sizing.
   • Increasingly optimized for plasmid DNA and mRNA/gene-therapy quality control, where fragment-size distribution is a critical process and release parameter.

07Value chains and production pipelines#

Industrial pipeline of a biopharma CE-SDS/icIEF characterization run (USP <129>/<1053> / 21 CFR Part 11)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Sample preparation      │ ───> │ 2. Capillary/chip loading  │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Detection                │ <─── │ 3. High-voltage separation │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Peak/band assignment   │ ───> │ 6. Characterization report │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Sample preparation

The protein sample is denatured with SDS and a reducing or non-reducing agent (for CE-SDS) or brought to a defined ampholyte mixture (for icIEF), or the nucleic-acid sample is diluted to the chip’s loading range.

Stage 2: Capillary or chip loading

The prepared sample is injected into a fused-silica capillary by pressure or electrokinetic injection, or loaded into a disposable microfluidic chip’s sample wells.

Stage 3: High-voltage separation

An applied electric field, often tens of kilovolts, moves charged species through the capillary or chip channel at rates determined by size (CE-SDS), isoelectric point (icIEF), or size and charge together (nucleic-acid fragments).

Stage 4: Detection

UV absorbance, laser-induced fluorescence, whole-capillary camera imaging, or mass-spectrometry detection captures the separated species as they migrate or reach their focused position.

Stage 5: Peak or band assignment

Electropherogram-integration or image-analysis software assigns each peak or band to a specific species — a purity component, a charge variant, or a nucleic-acid fragment size — and calculates its relative abundance.

Stage 6: Characterization report

The compiled purity, charge-variant or fragment-size profile is compared against a validated method specification under USP <129>/<1053>, with a 21 CFR Part 11-compliant audit trail for GxP release or characterization filings.